Gustav Paumgartner

1.5k citations
11 papers · 1.1k indexed · 1 hit paper · h-index 9
Topics
Drug Transport and Resistance Mechanisms (4 papers)Liver Diseases and Immunity (4 papers)Liver Disease Diagnosis and Treatment (3 papers)
Partner nations
GermanyUnited States

In The Last Decade

Gustav Paumgartner

11 papers receiving 1.1k citations

Hit Papers

Ursodeoxycholic acid in cholestatic liver disease: Mechan...20022026201020182002100200300400500

Peers

Gustav Paumgartner
Comparison fields: 5 of 83
  • Oncology 554
  • Surgery 471
  • Hepatology 464
  • Epidemiology 449
  • Pulmonary and Respiratory Medicine 144
Replace Ronald Oude Elferink with:
Ronald Oude Elferink Netherlands
Simon Hohenester Germany
S. Güldutüna Germany
Katryn N. Furuya United States
J. Marleen L. de Vree Netherlands
Adolf Stiehl Germany
Dalila Habès France
Jenneke A. Juijn Netherlands
Toshiharu Tsuzuki Japan
Marcus A. Wörns Germany
Gustav Paumgartner relative to Ronald Oude Elferink Netherlands Ronald Oude Elferink's profile →
Citations per field
00.5×1.5×2.1×
Ronald Oude Elferink · 1×
Citations per year

Countries citing papers authored by Gustav Paumgartner

Since Specialization
Citations

This map shows the geographic impact of Gustav Paumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustav Paumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustav Paumgartner more than expected).

Fields of papers citing papers by Gustav Paumgartner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustav Paumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustav Paumgartner. The network helps show where Gustav Paumgartner may publish in the future.

Co-authorship network of co-authors of Gustav Paumgartner

This figure shows the co-authorship network connecting the top 25 collaborators of Gustav Paumgartner. A scholar is included among the top collaborators of Gustav Paumgartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustav Paumgartner. Gustav Paumgartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1
Ursodeoxycholic acid in cholestatic liver disease: Mechanisms of action and therapeutic use revisitedbreakdown →
515
2 204
3 8
4 6
5 169
6 80
7 34
8 16
9 2
10 72
11
Determination of the pK values of 5-aminosalicylic acid and N-acetylaminosalicylic acid and comparison of the pH dependent lipid-water partition coefficients of sulphasalazine and its metabolites.
27

About Gustav Paumgartner

Gustav Paumgartner is a scholar working on Hepatology, Pharmaceutical Science and Clinical Biochemistry, having authored 11 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Liver Diseases and Immunity (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Hepatology (464 citations), Oncology (554 citations) and Pharmacology (117 citations). Gustav Paumgartner has collaborated with scholars based in Germany and United States. Frequent co-authors include Ulrich Beuers, Gerd A. Kullak‐Ublick, James L. Boyer, Frank Dombrowski, Dietrich Keppler, M Bilzer, Frieder Berr, Robert M. Hoffmann, Ulrich Spengler and Gert Riethmüller. Their work appears in journals such as Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026